triazoles has been researched along with glucagon-like peptide 2 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aaboe, K; Deacon, CF; Holst, JJ; Knop, FK; Krarup, T; Madsbad, S; Vilsbøll, T | 1 |
| Barrett, DG; Beavers, LS; Briere, DA; Coskun, T; Dubois, SL; Efanov, AM; Franciskovich, JB; Michael, MD; O'Farrell, LS; Syed, SK | 1 |
| Askov-Hansen, C; Hartmann, B; Henriksen, DB; Holst, JJ; Jeppesen, PB; Lund, P | 1 |
| Hartmann, B; Holst, J; Okawada, M; Sueyoshi, R; Teitelbaum, DH; Woods Ignatoski, KM | 1 |
1 trial(s) available for triazoles and glucagon-like peptide 2
| Article | Year |
|---|---|
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Administration Schedule; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Metformin; Middle Aged; Peptide YY; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles | 2010 |
3 other study(ies) available for triazoles and glucagon-like peptide 2
| Article | Year |
|---|---|
Activation of prostaglandin E receptor 4 triggers secretion of gut hormone peptides GLP-1, GLP-2, and PYY.
Topics: Animals; Cells, Cultured; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Intestinal Mucosa; Mice; Peptide YY; Real-Time Polymerase Chain Reaction; Receptors, Prostaglandin E, EP4 Subtype; Thiophenes; Triazoles | 2013 |
Effect of glucagon-like peptide-2 exposure on bone resorption: Effectiveness of high concentration versus prolonged exposure.
Topics: Adult; Area Under Curve; Biomarkers; Bone Resorption; Collagen Type I; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Female; Glucagon-Like Peptide 2; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Peptide Fragments; Pyrazines; Sitagliptin Phosphate; Triazoles | 2013 |
Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model.
Topics: Adaptation, Physiological; Amylases; Animals; Blood Glucose; Cell Proliferation; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Glucagon-Like Peptide 2; Glucagon-Like Peptide-2 Receptor; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Mice; Receptor, IGF Type 1; Receptors, Glucagon; Short Bowel Syndrome; Sodium-Glucose Transporter 1; Triazoles; Up-Regulation | 2014 |